Skip to main content

Ofloxacin

 

1. Generic & Brand Names

  • Generic: Ofloxacin

  • Brands: Floxin® (global), Ocuflox® (ophthalmic), Tarivid® (EU/Asia)

  • Formulations:

    • Tablets (200mg, 300mg, 400mg)

    • IV infusion (200mg/50mL, 400mg/100mL)

    • Ophthalmic/Otic solutions (not for systemic use)

2. Drug Class & Mechanism

  • Class: Fluoroquinolone antibiotic (2nd gen)

  • Mechanism: Inhibits DNA gyrase/topoisomerase IV → bactericidal

  • Spectrum:

    • Gram-negative: E. coli, K. pneumoniae, P. aeruginosa

    • Gram-positive: S. pneumoniae (limited), S. aureus (MSSA)

    • Atypicals: Chlamydia, Mycoplasma

    • Anaerobic: B. fragilis (moderate)

3. FDA-Approved Uses

Infection TypeKey PathogensStatus
Lower Respiratory TractS. pneumoniae, H. influenzaeAlternative*
Acute Bacterial COPD ExacerbationsH. influenzae, M. catarrhalisRestricted*
Uncomplicated UTIE. coli, K. pneumoniaeLast-line
Complicated UTI/PyelonephritisP. aeruginosaReserved
ProstatitisEnterobacteriaceaeAlternative

⚠️ FDA RESTRICTIONS (2016/2023):

  • Avoid for sinusitis, bronchitis, uncomplicated UTIs unless no alternatives exist.

  • Reserve for:

    • Pyelonephritis with suspected Pseudomonas

    • Multi-drug resistant (MDR) infections

4. Dosing Regimens

Infection TypeAdult DoseDuration
Lower Respiratory400 mg PO/IV q12h7-14 days
Uncomplicated UTI200 mg PO q12h3-7 days
Complicated UTI/Pyelonephritis200-400 mg PO/IV q12h10-21 days
Prostatitis300 mg PO q12h6 weeks
Renal Adjustment:

  • CrCl 20-50 mL/min: ↓ dose 50%

  • CrCl <20 mL/min: Avoid systemic use

5. Black Box Warnings (FDA)

  1. Tendon Rupture:

    • Achilles > shoulder/hand tendons

    • Risk ↑ in: >60 yrs, steroid use, kidney transplant

  2. Peripheral Neuropathy:

    • Irreversible nerve damage (pain/tingling/weakness)

  3. CNS Effects:

    • Insomnia, psychosis, suicidal ideation

  4. Exacerbates Myasthenia Gravis:

    • May cause respiratory failure

6. Side Effects

Common (≥10%)Serious (Discontinue Immediately)
Nausea/vomitingTendon rupture
HeadacheQT prolongation → Torsades
DiarrheaAortic dissection
PhotosensitivityHypersensitivity reactions
DizzinessC. difficile colitis

7. Critical Drug Interactions

MedicationRisk
NSAIDs↑ Seizure risk
Corticosteroids↑ Tendon rupture risk
Antidiabetics↑ Hypoglycemia (glipizide/glyburide)
Theophylline↑ Levels → toxicity (monitor serum)
Antacids/Ca²⁺/Fe²⁺↓ Absorption (separate by 4h)

8. Resistance & Stewardship

  • UTI Resistance Concerns:

    35% E. coli resistant in US outpatient UTIs (IDSA 2023)

  • Avoid For:

    • Strep throat, viral infections, mild skin infections

    • Pediatric patients (cartilage damage risk)

  • First-Line Alternatives:

    • Uncomplicated UTI: Nitrofurantoin, Fosfomycin

    • Respiratory: Amoxicillin-clavulanate, Doxycycline

9. IV-to-PO Transition

  • Bioavailability: 98% oral → switch to PO as soon as clinically feasible

  • IV Administration:

    • Infuse 400 mg over ≥60 min (rapid infusion → hypotension)

    • Avoid IV for >10 days (↑ thrombophlebitis risk)

10. Storage & Handling

  • Tablets: 15-30°C (59-86°F); protect from light/moisture

  • Oral Suspension: Not commercially available (compounded)

  • IV Solution: Discard unused portions; refrigerate intact vials

Clinical Practice Guidelines

✅ Appropriate Use:

  • MDR Pseudomonas UTIs/prostatitis

  • Atypical pneumonia in penicillin-allergic patients

  • Institutional protocols with confirmed susceptibility
    ❌ Avoid:

  • Uncomplicated infections

  • Patients with tendon/CNS disorders

⚠️ Mandatory Counseling:

  • "Stop drug for tendon pain/mood changes."

  • "Avoid sunlight/sunlamps (use SPF 50+)."

  • "Take 2h before/4h after antacids/vitamins."

Ofloxacin vs. Other Fluoroquinolones

ParameterOfloxacinCiprofloxacinLevofloxacin
Pseudomonas Coverage+++++++
Respiratory PenetrationModerateLowHigh
QTc Prolongation RiskHighModerateHigh
Urinary ConcentrationHighHighModerate

📊 Efficacy Data:

  • Complicated UTI cure rate: 82% vs. 85% for ciprofloxacin (J Antimicrob Chemother)

  • Resistance in respiratory isolates: S. pneumoniae (15-25%), H. influenzae (5-10%)

Prescribing Status: Restricted in US/EU; requires justification of "no suitable alternatives."

💡 Key Insight: Reserve for confirmed MDR infections in consultation with infectious disease specialists. Always perform culture/susceptibility testing before use.

Comments

Post a Comment

Popular posts from this blog

First-Year BPT Study Guide: Units 1 to 4 Explained for Physiotherapy Students

  🔹 Introduction Starting your Bachelor of Physiotherapy (BPT) journey? The first year lays the essential groundwork for becoming a skilled physiotherapist. This blog explains the first-year BPT Units 1 to 4—key concepts that cover physiotherapy basics, anatomy, physiology, and professional ethics. Whether you're studying for exams or building your foundation, these insights are crucial for academic and clinical success. 🔹 Unit 1: Introduction to Physiotherapy Keywords: introduction to physiotherapy, first-year physiotherapy course, BPT basics In this unit, students explore the history, scope, and branches of physiotherapy. From treating joint pain to supporting neurological rehabilitation, physiotherapy offers diverse career opportunities. The profession originated in ancient times and gained formal recognition during wartime rehabilitation. Specialties include: Orthopedic physiotherapy Neurological physiotherapy Pediatric physiotherapy Cardiopulmonary physiot...
Post a Comment
Read more

⚠️ Contraindications of Electrotherapy Modalities: Learn Fast

  Electrotherapy is a powerful tool in physiotherapy — but using it safely is just as important as using it effectively. Here's a fast-track guide to the contraindications of common electrotherapy modalities for students, interns, and clinicians. 🚫 What Are Contraindications? These are conditions or situations where electrotherapy should NOT be used due to risk of harm or complications. ⚡ Common Electrotherapy Modalities & Their Contraindications 🔌 1. TENS (Transcutaneous Electrical Nerve Stimulation) Avoid if: Patient has a pacemaker or implantable defibrillator Over pregnant abdomen or uterus Over malignant tumors Broken, infected, or anesthetic skin On carotid sinus area (risk of cardiac reflex) Epileptic patients (caution advised) 🔄 2. IFT (Interferential Therapy) Avoid if: Metal implants in the treatment area Open wounds or skin conditions Pregnancy (especially lower abdomen/lumbar) Over the eyes, carotid sinus, or chest...
Post a Comment
Read more

Metoprolol – heart rate control

  1.  Mechanism & Class Class:  β₁-Selective Beta-Blocker ( Cardioselective ) Action: Blocks cardiac β₁-receptors → ↓  sinus node firing rate  and  AV conduction Reduces resting/peak heart rate (HR), myocardial oxygen demand Formulations: Tartrate (IR):  Short-acting (dosed BID) -  Lopressor® Succinate (ER):  24-hour control -  Toprol-XL® 2.  Key Indications for Rate Control Condition Target HR Formulation Atrial Fibrillation (AFib) 60-100 bpm Tartrate BID Sinus Tachycardia 60-100 bpm Succinate daily Post-MI Tachycardia 50-60 bpm Tartrate BID → Succinate SVT Acute IV → PO IV/PO Tartrate 3.  Dosing Protocols Scenario Initial Dose Titration Max Dose Chronic AFib Tartrate 25 mg BID ↑ by 25 mg BID q3-7d 100 mg BID Acute SVT/AFib (IV) 2.5-5 mg IV slow Repeat q5min × 3 15 mg Post-MI Tartrate 25 mg BID → Switch to Succinate 100 mg daily 200 mg/day Anxiety-Induced Tachycardia Succinate 25 mg daily ↑ 25 mg weekly 200 mg/day Goal HR:...
Post a Comment
Read more